A Study of OMP-313M32 in Subjects With Locally Advanced or Metastatic Solid Tumors
Clinical trial NCT03119428 · TERMINATED
Trial details
- NCT number
- NCT03119428
- Sponsor
- OncoMed Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-02
- Primary completion
- 2019-05-15
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.